Carlos Azuaje

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis

Esteban Ribera, Carlos Azuaje, Rosa María López et al. · Journal of Antimicrobial Chemotherapy · 2007 · 59 citations · Full text

Steady-State Pharmacokinetics of a Double-Boosting Regimen of Saquinavir Soft Gel plus Lopinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Infected Adults

Esteban Ribera, Rosa María López, M. Medina Díaz et al. · Antimicrobial Agents and Chemotherapy · 2004 · 57 citations · Full text

Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen

Esteban Ribera, Carlos Azuaje, Rosa María López et al. · AIDS · 2006 · 48 citations

Once-Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV-Infected Patients With Standard Tuberculosis Therapy (TBQD Study)

Esteban Ribera, Carlos Azuaje, Rosa María López et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 27 citations

Health-Related Quality of Life in HIV-Infected Naive Patients Treated with Nelfinavir or Nevirapine Associated with ZDV/3TC (the COMBINE-QoL Substudy)

Alfonso Casado, Ezequiel Consiglio, Elena Ferrer et al. · HIV Clinical Trials · 2004 · 17 citations · Full text